Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice

Ann Allergy Asthma Immunol. 2016 Dec;117(6):703-707. doi: 10.1016/j.anai.2016.08.006. Epub 2016 Oct 6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Allergic Agents / therapeutic use*
  • Chronic Disease / drug therapy*
  • Humans
  • Omalizumab / therapeutic use*
  • Urticaria / drug therapy*

Substances

  • Anti-Allergic Agents
  • Omalizumab